NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Origincell Technology Group

Origincell Technology Group

Private
ShanghaiHealthcare & Life Scienceshttps://www.origincell.com/

Last Round

Private Equity

Apr 9, 2026

Est. Valuation

$210.1M

Total Funding Raised

$751.69M

Company Overview

Origincell Technology Group is a biotechnology company that provides cell banking services, automated biological sample storage equipment, and develops tumor immunotherapy solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

biobankingcell bankingcryopreservationautomated sample storagebiotech equipmentcold chain storagebiobank softwarestem cell storagecryogenic storagelab automation5G IoTdigital twinpredictive maintenancebiotech infrastructuresmart lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Origincell Technology Group Comparables

Compare Origincell Technology Group with similar companies based on industry and business-model similarity.

Origincell Technology Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genepoint Technologies Co., Ltd.
84%
Haier Smart Home
77%
ASKION GmbH
77%

Origincell Technology Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityApr 9, 2026
Series B ExtensionFeb 28, 2023
Series BJul 1, 2022
Series AMay 30, 2022
Series AMar 14, 2022
Series A
Jan 18, 2021

Origincell Technology Group Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 13, 2019

    $11.4M raised, led by Qiming Venture Partners.

  • Jul 16, 2014

    $242M raised from Canature Health Technology Group and Qu Jianguo.

Origincell Technology Group Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Origincell Technology Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Origincell Technology Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range17
Year Founded2014
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.